Ilaria Avonto - Concepedia

Author

Ilaria Avonto

Azienda Ospedaliero Universitaria San Giovanni Battista

Also Known As

I. Avonto, Ilaria Avonto, Riccardo Boverio

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliero Universitaria San Giovanni Battista St. Eugenio Hospital Fondazione Gimema Onlus Casa Sollievo della Sofferenza Istituti di Ricovero e Cura a Carattere Scientifico

About

Ilaria Avonto is an author at Azienda Ospedaliero Universitaria San Giovanni Battista specializing in oncology, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	1K
2	Medicine	3	3	889
3	Pharmacology	2	2	866
4	Clinical Trials	2	2	866
5	Pathology	1	1	58

Ilaria Avonto

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial Antonio Palumbo, Tommaso Caravita, Emanuela Merla, The Lancet Hematological MalignancyOncologyMetronomic TherapyHematologyPharmacology	2006	808
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo, Blood	2006	181
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma Antonio Palumbo, Francesca Gay, Sara Bringhen, Annals of Oncology Hematological MalignancyAdvanced Multiple MyelomaHematologyOncologyRadiation Oncology	2008	126
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma Antonio Palumbo, Ilaria Avonto, Benedetto Bruno, European Journal Of Haematology Hematological MalignancyHealth SciencesMedicineHematologyClinical Trials	2006	58
Thalidomide–dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide–dexamethasone: a case‐matched study in advanced multiple myeloma Massimo Offidani, Laura Corvatta, Patrizia Falco, European Journal Of Haematology	2007	30
Intermediate-Dose Melphalan (100 mg/m2)/Bortezomib/Thalidomide/Dexamethasone and Stem Cell Support in Patients with Refractory or Relapsed Myeloma Antonio Palumbo, Ilaria Avonto, Benedetto Bruno, Clinical Lymphoma & Myeloma Hematological MalignancyStem Cell SupportMedicineHematologyMyeloid Neoplasia	2006	23
Time to first disease progression, but not β2‐microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy Antonio Palumbo, Sara Bringhen, Patrizia Falco, Cancer	2007	21
Platelet gel for the treatment of traumatic loss of finger substance. R. Balbo, Ilaria Avonto, Dario Marenchino, PubMed	2010	21
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients. Marco Ladetto, G Pagliano, Ilaria Avonto, Blood	2007	18
Velcade™ Plus Melphalan, Prednisone, and Thalidomide (V-MPT) for Advanced Multiple Myeloma. Antonio Palumbo, Maria Teresa Ambrosini, Patrizia Pregno, Blood	2005	13

Page 1